Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension - Wikidata - awgldk - TriplyDB

Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension

Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension

http://www.wikidata.org/entity/Q36678295

about

Vascular Complications of Cancer Chemotherapy Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening.Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors.Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors.Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options.Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats.Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.

P2860

Q26766269-89FC3FC3-DBFB-442C-A3FA-6B796CA376C9 Q30008769-646C07A3-4922-4998-982E-B1E20FB1B77F Q34143251-78FED454-FC12-46C0-B37A-07D7DB3ABF99 Q35995112-6AEA01CD-7194-4B30-8DE6-BB0578F2F991 Q36106439-5F025D23-1C44-4D6B-9BDC-7E9F943BC7B1 Q38156262-560FD0AB-49DC-4128-B245-718D0F49ADAC Q38757141-5C350D85-A3E7-4784-A749-E2D720AF4213 Q42323403-A84EB1DA-B92F-472A-ABD0-B916AEE30C30 Q50204127-F2AA92AE-4BA9-47A2-8E3B-D03FBE80663D

P2860

Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension

http://www.wikidata.org/entity/Q36678295

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@ast

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@en

type

label

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@ast

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@en

prefLabel

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@ast

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@en

P1433

Q36678295-8B9C6D8F-1F55-48AD-B8F6-F83268CE247F

P1476

Q36678295-D361E9FE-DEB4-4951-BAC6-189536D2D026

P2093

Q36678295-012F7424-E6DA-40D3-9202-6DFA0689D446

Q36678295-8911FD4E-7EF5-4BB0-BB07-74C323F4550C

Q36678295-C9C9E71F-4163-4155-8E00-88BB2EC24767

P2860

Q36678295-030C649D-BE9B-4DE0-9E3A-94BEF8E42DD9

Q36678295-059A9746-5169-4BF9-9239-59E25EA0D97B

Q36678295-06DA6AFD-CAD7-4765-9D6B-C6417BB37591

Q36678295-085C99D8-3006-4073-B295-F349511761C8

Q36678295-08756A41-5AF8-4C82-8C12-9F681D784338

Q36678295-11AD9935-9BAD-4483-8DA1-D2F1B10F9CEF

Q36678295-11E11A90-4622-41D9-A734-D6479CBA03FF

Q36678295-22430EB6-AEEF-4401-AB41-74AE0876DB88

Q36678295-24C9A9DA-A258-475E-ACC3-D4B5A86035F0

Q36678295-2769F56E-7D43-41D9-9B3F-004A2DD9F609

P2888

Q36678295-15746634-DDF9-4CE8-8C29-45491B278D1B

P304

Q36678295-A918E5DE-BD4A-4038-A50B-956EBA79A51D

P31

Q36678295-22E7511F-7D55-4F64-84B5-7DF478A542B4

Q36678295-4E78779D-0BE1-4DB5-9FA6-C1B8797DA7AA

P356

Q36678295-27CA67FD-6BFA-4756-9642-20118BE95C6C

P433

Q36678295-49874D45-3CC3-4DF9-A4D2-C27A7EC9B9BD

P478

Q36678295-B448B153-78A8-4EFD-A17F-FAA15564CE34

P577

Q36678295-0962305D-9381-4499-96FA-D405D9B6F8C0

Q36678295-723E75B9-D936-4457-A5CD-5A716EAE1B94

P5875

Q36678295-1004EF1D-775E-4A21-98EE-6655A875BA55

P698

Q36678295-B3656908-FB6B-45AD-A36B-47F141B4B2BB

P921

Q36678295-C383F78F-0DAE-4BAB-B2D6-5564609C6BFF

Q36678295-E73F4FA4-09FA-45C7-8B43-2D90607C403B

P932

Q36678295-D6B315E2-2376-4FF3-94F4-B40B99B6FAFF

P356

S10456-012-9327-4

P1433

P1476

Therapeutic potential of nitri ...... inhibitor-induced hypertension

@en

P2093

Gabriela Kovacova

http://www.w3.org/2001/XMLSchema#string

Olga Pechanova

http://www.w3.org/2001/XMLSchema#string

Peter Kruzliak

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

The biology of VEGF and its receptors

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF

Angiogenesis in cancer, vascular, rheumatoid and other disease

Role of angiogenesis in tumor growth and metastasis

Mechanisms of angiogenesis and arteriogenesis

P2888

s10456-012-9327-4

P304

289-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10456-012-9327-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233829615

http://www.w3.org/2001/XMLSchema#string

P698

23203441

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

arterial hypertension

P932

3595470

http://www.w3.org/2001/XMLSchema#string